IMCC
IM CANNABIS (IMCC)
NASDAQ
$0.29-$0.004 (-1.26%)
Price as of Jun 03, 2026 6:48 PM EDT
  • $1.8M
    Market Cap
  • -89.77%
    1-Year Change
  • Drug Manufacturers - Specialty & Generic
    Industry

Key Performance

More
  • Earnings Score: N/A
  • Momentum Score: 30
  • True Yield: N/A
  • Financial Health Score: N/A
TradeSmith Loading

Latest Research & News

IM Cannabis Raises US$225,000 of Gross Proceeds in Convertible Note Financing

IM Cannabis Corp. (NASDAQ: IMCC) announced the closing of a US$225,000 convertible note financing with an institutional investor. The convertible note bears 8% interest (increasing to 14% upon default) and includes warrants to purchase 781,250 common shares at C$0.40 per share. The company intends to use net proceeds for general corporate purposes and has agreed to file a resale registration statement with the SEC.

06/03/2026, 4:01 PM • Benzinga

IM Cannabis Corp. Announces First Quarter 2026 Financial Results

IM Cannabis Corp. (NASDAQ: IMCC) reported Q1 2026 results with revenues of $8.7 million, gross profit of $1.4 million, and a net loss of $2.5 million ($0.38 per share). The company reduced general and administrative expenses by 22% year-over-year and completed convertible note financings to support liquidity management. Operations continue in Israel and Germany with focus on cost optimization and strategic opportunities.

05/13/2026, 4:01 PM • Benzinga

IM Cannabis Raised US$550,000 of Gross Proceeds in Convertible Note Financings

IM Cannabis Corp (NASDAQ: IMCC) announced the closing of convertible note financings totaling US$550,000 in gross proceeds. The company issued two convertible notes with warrants to institutional investors, with net proceeds to be used for general corporate purposes. The notes feature conversion prices tied to market conditions and include standard protective provisions for investors.

05/07/2026, 4:30 PM • Benzinga

IM Cannabis Reports 2025 Results: Revenue of C$54.7 Million with Over 134% Growth in Germany and Positive Operating Cash Flow

IM Cannabis Corp. reported 2025 full-year revenue of C$54.7 million with strong 134% growth in Germany, now representing 66% of total revenue. The company achieved positive operating cash flow of C$4.7 million, a significant turnaround from 2024, and strengthened its cash position to C$3.3 million through strategic financings. Additionally, IMC announced plans to diversify into defense technology through a proposed acquisition of 51% stake in Polish company Black Axe Technologies.

03/31/2026, 7:55 AM • Benzinga

IM Cannabis Raises US$2,171,660.40 in Note Purchase Agreements

IM Cannabis Corp. (NASDAQ:IMCC) announced it has raised US$2.17 million through two note purchase agreements with a third-party lender to manage liquidity requirements. The First Note of US$1.54 million and Second Note of US$632,911.50 both carry 8% interest (increasing to 14% upon default) with 18-month maturities and conversion options. Approximately US$1 million of proceeds were used to repay existing creditors, with remaining funds allocated to working capital and strategic initiatives.

01/26/2026, 4:53 PM • Benzinga

IM Cannabis Announces Board Changes and Strategic Decision to Identify Additional Business Opportunities

IM Cannabis Corp. announced board changes, with two directors resigning and two new directors appointed. Oz Adler was named Board Chairman, and the company plans to explore additional business opportunities to enhance long-term growth.

09/16/2025, 6:07 AM • Benzinga

IM Cannabis Closes Private Placement for Gross Proceeds of Approximately US$4.1 Million

IM Cannabis Corp. successfully closed a private placement offering, raising approximately US$4.1 million by issuing 2,050,000 units at C$2.7427 per unit, with each unit consisting of a common share or pre-funded warrant and a common share purchase warrant.

07/31/2025, 5:24 PM • Benzinga

Peers

Statistics

More
Day Range
$0.28
$0.32
$0.29
1-Year Range
$0.22
$3.55
$0.29
Latest Close$0.29
Change
-$0.03 (-8.69%)
Volume494,869
Market Cap$1.8M
Shares Outstanding6.2M
P/E (TTM)-0.11
Diluted EPS (TTM)-$2.67
Enterprise Value$13.4M

Information as of 06/02/2026

Company Profile

IM CANNABIS CORP
IM CANNABIS CORP
https://imcannabis.com
$1.8M
Market Cap
-$11.8M
Net Income
Sector: Healthcare
Industry: Drug Manufacturers - Specialty & Generic
3606 ? 833 Seymour Street, Vancouver, BC, Canada, V6B 0G4
972 5 44331111

IM Cannabis Corp. engages in importation, distribution and sale of medical cannabis products in Israel and Germany. It provides medical cannabis dried flowers; and full-spectrum cannabis extracts under the IMC, BLKMT, and LOT420 brands. The company serves medical patients. IM Cannabis Corp. was founded in 2008 and is headquartered in Vancouver, Canada.

Key Executives

  • Oren Shuster
  • Richard Balla
  • Eyal Fisher
  • Asi Levi
  • Advocate Michal Lebovitz Nissimov

Current Ownership Distribution

  • Mutual Funds50.2M (65.93%)
  • Institutions25.9M (34.07%)
  • Insiders0 (0.00%)
  • Other0 (0.00%)